Managers / Q3 2020 · view latest →
Prescott General Partners LLC
CIK 0001538653 · 2200 BUTTS ROAD, SUITE 320, BOCA RATON, FL, 33431 · 561-314-0800
Summary
Prescott General Partners LLC reported $2.5B in U.S.-listed holdings across 10 positions for Q3 2020.
The portfolio is heavily concentrated: W alone accounts for 47.3% of reported value.
The book was largely unchanged from Q2 2020.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 85.4% · $2.2B
- Other · 14.6% · $368M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| VAPOTHERM INC | ADDED | +672.9K | 2.56M | −$3M | $74M |
| WWAYFAIR INC | TRIMMED | −542.1K | 4.10M | +$276M | $1.2B |
| SYXUSDSYSTEMAX INC | HELD | −27.4K | 1.78M | +$5M | $43M |
| CACCCREDIT ACCEP CORP MICH | HELD | +0 | 1.74M | −$140M | $589M |
| WRLDWORLD ACCEP CORP DEL | HELD | +0 | 2.04M | +$82M | $215M |
| YELPYELP INC | HELD | +0 | 5.15M | −$16M | $103M |
| CIMPRESS PLC | HELD | +0 | 3.91M | −$5M | $294M |
| BFHALLIANCE DATA SYSTEMS CORP | HELD | +0 | 265.4K | −$833,000 | $11M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2020
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | WWAYFAIR INChistory → | CL A | 47.26% | $1.2B | 4.10M |
| 2 | CACCCREDIT ACCEP CORP MICHhistory → | COM | 23.34% | $589M | 1.74M |
| 3 | CIMPRESS PLC | SHS EURO | 11.64% | $294M | 3.91M |
| 4 | WRLDWORLD ACCEP CORP DELhistory → | COM | 8.52% | $215M | 2.04M |
| 5 | YELPYELP INChistory → | CL A | 4.10% | $103M | 5.15M |
| 6 | VAPOTHERM INC | COM | 2.94% | $74M | 2.56M |
| 7 | SYXUSDSYSTEMAX INChistory → | COM | 1.69% | $43M | 1.78M |
| 8 | BFHALLIANCE DATA SYSTEMS CORPhistory → | COM | 0.44% | $11M | 265.4K |
| 9 | LCTXLINEAGE CELL THERAPEUTICS IN | COM | 0.07% | $2M | 1.85M |
| 10 | AGEGBPAGEX THEREPEUTICS INC | COM | 0.01% | $150,000 | 185.2K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.4B | 10 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.4B | 10 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.4B | 10 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.4B | 9 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.3B | 10 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.4B | 9 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.5B | 9 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $1.6B | 9 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $1.8B | 7 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.7B | 9 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $1.6B | 10 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1.6B | 10 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $1.3B | 10 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $1.2B | 10 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.3B | 10 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.5B | 12 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $2.2B | 12 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $2.9B | 15 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $3.0B | 14 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $3.1B | 9 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $2.9B | 10 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $2.4B | 10 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $2.5B | 10 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $2.3B | 10 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $1.2B | 9 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $2.2B | 10 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $2.5B | 10 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $2.6B | 10 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $2.4B | 10 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $2.3B | 11 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.